PAA are clearly not in the same category as biotechs with no prospects and no cashflow. They have both (but far from enough of the latter), and as they progress their products to commercial production they are going to get more and more attention in the market. We will look back on the current price as a dream opportunity gone begging.
- Forums
- ASX - By Stock
- PAA
- Ann: Change of Director's Interest Notice
Ann: Change of Director's Interest Notice, page-18
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.5¢ |
Change
-0.020(8.89%) |
Mkt cap ! $81.16M |
Open | High | Low | Value | Volume |
20.0¢ | 21.0¢ | 19.5¢ | $331.9K | 1.617M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 440882 | 20.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.0¢ | 12736 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 203382 | 0.205 |
9 | 278609 | 0.200 |
9 | 134197 | 0.195 |
16 | 349570 | 0.190 |
6 | 478648 | 0.185 |
Price($) | Vol. | No. |
---|---|---|
0.210 | 12736 | 3 |
0.215 | 120000 | 1 |
0.235 | 25000 | 1 |
0.240 | 60977 | 5 |
0.245 | 41137 | 3 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online